Role and therapeutic potential of the pro-longevity factor FOXO and its regulators in neurodegenerative disease

Frontiers in Pharmacology

Volumn 3 FEB, Issue , 2012, Pages

  Neri, Christian ^a  

^a INSERM   (France)

Author keywords

Disease; Foxo; Longevity

Indexed keywords

ADENYLATE KINASE; HEAT SHOCK TRANSCRIPTION FACTOR 1; HUNTINGTIN; IVERMECTIN; RESVERATROL; S6 KINASE; SIRTUIN 1; SIRTUIN 2; SOMATOMEDIN; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO;

ALZHEIMER DISEASE; ARTICLE; CELL SURVIVAL; DEGENERATIVE DISEASE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUNTINGTON CHOREA; LONGEVITY; NERVE CELL; NEUROMODULATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 84865964715     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00015     Document Type: Article

References (97)

1. Anselmi, C. V., Malovini, A., Roncarati, R., Novelli, V., Villa, F., Condorelli, G., Bellazzi, R., and Puca, A. A. (2009). Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res. 12, 95-104.
2. Apfeld, J., and Kenyon, C. (1999). Regulation of lifespan by sensory perception in Caenorhabditis elegans. Nature 402, 804-809.
3. Bates, E. A., Victor, M., Jones, A. K., Shi, Y., and Hart, A. C. (2006). Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J. Neurosci. 26, 2830-2838.
4. Baur, J. A., Chen, D., Chini, E. N., Chua, K., Cohen, H. Y., De Cabo, R., Deng, C., Dimmeler, S., Gius, D., Guarente, L. P., Helfand, S. L., Imai, S., Itoh, H., Kadowaki, T., Koya, D., Leeuwenburgh, C., Mcburney, M., Nabeshima, Y., Neri, C., Oberdoerffer, P., Pestell, R. G., Rogina, B., Sadoshima, J., Sartorelli, V., Serrano, M., Sinclair, D. A., Steegborn, C., Tatar, M., Tissenbaum, H. A., Tong, Q., Tsubota, K., Vaquero, A., and Verdin, E. (2010). Dietary restriction: standing up for sirtuins. Science 329, 1012-1013.
5. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., Pistell, P. J., Poosala, S., Becker, K. G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K. W., Spencer, R. G., Lakatta, E. G., Le Couteur, D., Shaw, R. J., Navas, P., Puigserver, P., Ingram, D. K., De Cabo, R., and Sinclair, D. A. (2006). Resveratrol improves health and survival of mice on a highcalorie diet. Nature 444, 337-342.
6. Berdichevsky, A., Viswanathan, M., Horvitz, H. R., and Guarente, L. (2006). C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 125, 1165-1177.
7. Bizat, N., Peyrin, J. M., Haik, S., Cochois, V., Beaudry, P., Laplanche, J. L., and Neri, C. (2010). Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. J. Neurosci. 30, 5394-5403.
8. Burgess, D. J. (2011). Model organisms: the dangers lurking in the genetic background. Nat. Rev. Genet. 12, 742.
9. Burnett, C., Valentini, S., Cabreiro, C., Goss, M., Somogyvári, M., Piper, M., Hoddinott, M., Sutphin, G., Leko, V., Mcelwee, J., Vazquez-Manrique, R., Orfila, A., Ackerman, D., Au, C., Vinti, G., Riesen, M., Howard, K., Neri, C., Bedalov, A., Kaeberlein, M., Soti, C., Partridge, L., and Gems, D. (2011). Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482-485.
10. Cabreiro, F.,and Gems, D. (2010). Treating aging: progress toward dietary restriction mimetics. F1000 Biol. Rep. 2, 76.
11. Calnan, D. R., and Brunet, A. (2008). The FoxO code. Oncogene 27, 2276-2288.
12. Catoire, H., Pasco, M. Y., Abu-Baker, A., Holbert, S., Tourette, C., Brais, B., Rouleau, G.A., Parker, J.A.,and Neri, C. (2008). Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. Hum. Mol. Genet. 17, 2108-2117.
13. Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y. D., Ma, T., Thompson, R. C., Zhao, Y., Smith, L., Gasparini, L., Luo, Z., Xu, H.,and Liao, F. F. (2009). Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Proc. Natl. Acad. Sci. U.S.A. 106, 3907-3912.
14. Chiacchiera, F., Matrone, A., Ferrari, E., Ingravallo, G., Lo Sasso, G., Murzilli, S., Petruzzelli, M., Salvatore, L., Moschetta, A., and Simone, C. (2009). p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alphato FoxO-dependent transcription. Cell Death Differ. 16, 1203-1214.
15. Chiacchiera, F., and Simone, C. (2009). Inhibition of p38alpha unveils an AMPK-FoxO3A axis linking autophagy to cancer-specific metabolism. Autophagy 5, 1030-1033.
16. Chiacchiera, F., and Simone, C. (2010). The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle 9, 1091-1096.
17. Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., and Dillin, A. (2006). Opposing activities protect against age-onset proteotoxicity. Science 313, 1604-1610.
18. Cohen, E., Paulsson, J. F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G., Adame, A., Pham, H. M., Holzenberger, M., Kelly, J. W., Masliah, E., and Dillin, A. (2009). Reduced IGF1 signaling delays age-associated proteotoxicity in mice. Cell 139, 1157-1169.
19. Dai, H., Kustigian, L., Carney, D., Case, A., Considine, T., Hubbard, B. P., Perni, R. B., Riera, T. V., Szczepankiewicz, B., Vlasuk, G. P., and Stein, R. L. (2010). SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J. Biol. Chem. 285, 32695-32703.
20. Dansen, T. B., and Burgering, B. M. (2008). Unravelling the tumorsuppressive functions of FOXO proteins. Trends Cell Biol. 18, 421-429.
21. Dasgupta, B., and Milbrandt, J. (2007). Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. U.S.A. 104, 7217-7222.
22. de la Torre-Ubieta, L., Gaudilliere, B., Yang, Y., Ikeuchi, Y., Yamada, T., Dibacco, S., Stegmuller, J., Schuller, U., Salih, D. A., Rowitch, D., Brunet, A., and Bonni, A. (2010). A FOXOPak1 transcriptional pathway controls neuronal polarity. Genes Dev. 24, 799-813.
23. Demontis, F., and Perrimon, N. (2009). Integration of insulin receptor/Foxo signaling and dMyc activity during muscle growth regulates body size in Drosophila. Development 136, 983-993.
24. Dietrich, M. O., Antunes, C., Geliang, G., Liu, Z. W., Borok, E., Nie, Y., Xu, A. W., Souza, D. O., Gao, Q., Diano, S., Gao, X. B., and Horvath, T. L. (2010). Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity. J. Neurosci. 30, 11815-11825.
25. El-Mir, M. Y., Detaille, D., R-Villanueva, G., Delgado-Esteban, M., Guigas, B., Attia, S., Fontaine, E., Almeida, A., and Leverve, X. (2008). Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J. Mol. Neurosci. 34, 77-87.
26. Essers, M. A., De Vries-Smits, L. M., Barker, N., Polderman, P. E., Burgering, B. M., and Korswagen, H. C. (2005). Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308, 1181-1184.
27. Flachsbart, F., Caliebe, A., Kleindorp, R., Blanche, H., Von Eller-Eberstein, H., Nikolaus, S., Schreiber, S.,and Nebel, A. (2009). Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. U.S.A. 106, 2700-2705.
28. Frojdo, S., Cozzone, D., Vidal, H., and Pirola, L. (2007). Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem. J. 406, 511-518.
29. Fulda, S., and Debatin, K. M. (2006). Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect. Prev. 30, 217-223.
30. Greer, E. L., and Brunet, A. (2005). FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24, 7410-7425.
31. Greer, E. L., Dowlatshahi, D., Banko, M. R., Villen, J., Hoang, K., Blanchard, D., Gygi, S. P., and Brunet, A. (2007). An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr. Biol. 17, 1646-1656.
32. Guo, W., Qian, L., Zhang, J., Zhang, W., Morrison, A., Hayes, P., Wilson, S., Chen, T., and Zhao, J. (2011). Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J. Neurosci. Res. 89, 1723-1736.
33. Harikumar, K. B., and Aggarwal, B. B. (2008). Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 1020-1035.
34. Herranz, D., and Serrano, M. (2010). SIRT1: recent lessons from mouse models. Nat. Rev. Cancer 10, 819-823.
35. Hoogeboom, D., Essers, M. A., Polderman, P. E., Voets, E., Smits, L. M.,and Burgering, B. M. (2008). Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. J. Biol. Chem. 283, 9224-9230.
36. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., Scherer, B., and Sinclair, D. A. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
37. Huang, H., Regan, K. M., Wang, F., Wang, D., Smith, D. I., Van Deursen, J. M., and Tindall, D. J. (2005). Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. U.S.A. 102, 1649-1654.
38. Huber, K.,and Superti-Furga, G. (2011). After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders. Bioorg. Med. Chem. 19, 3616-3624.
39. Jensen, V. L., Gallo, M., and Riddle, D. L. (2006). Targets of DAF-16 involved in Caenorhabditis elegans adult longevity and dauer formation. Exp. Gerontol. 41, 922-927.
40. Jeong, H., Cohen, D. E., Cui, L., Supinski, A., Savas, J. N., Mazzulli, J. R., Yates, J. R. III, Bordone, L., Guarente, L.,and Krainc, D. (2011). Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 18, 159-165.
41. Jiang, M., Wang, J., Fu, J., Du, L., Jeong, H., West, T., Xiang, L., Peng, Q., Hou, Z., Cai, H., Seredenina, T., Arbez, N., Zhu, S., Sommers, K., Qian, J., Zhang, J., Mori, S., Yang, X. W., Tamashiro, K. L., Aja, S., Moran, T. H., Luthi-Carter, R., Martin, B., Maudsley, S., Mattson, M. P., Cichewicz, R. H., Ross, C. A., Holtzman, D. M., Krainc, D.,and Duan, W. (2011). Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat. Med. 18, 153-158.
42. Ju, T. C., Chen, H. M., Lin, J. T., Chang, C. P., Chang, W. C., Kang, J. J., Sun, C. P., Tao, M. H., Tu, P. H., Chang, C., Dickson, D. W., and Chern, Y. (2011). Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease. J. Cell Biol. 194, 209-227.
43. Kerdiles, Y. M., Stone, E. L., Beisner, D. R., Mcgargill, M. A., Ch'En, I. L., Stockmann, C., Katayama, C. D.,and Hedrick, S. M. (2010). Foxo transcription factors control regulatory T cell development and function. Immunity 33, 890-904.
44. Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., Puigserver, P., Sinclair, D. A., and Tsai, L. H. (2007). SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 26, 3169-3179.
45. Kitamura, T., Kitamura, Y. I., Funahashi, Y., Shawber, C. J., Castrillon, D. H., Kollipara, R., Depinho, R. A., Kitajewski, J., and Accili, D. (2007). A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J. Clin. Invest. 117, 2477-2485.
46. Kleindorp, R., Flachsbart, F., Puca, A. A., Malovini, A., Schreiber, S., and Nebel, A. (2011). Candidate gene study of FOXO1, FOXO4, and FOXO6 reveals no association with human longevity in Germans. Aging Cell 10, 622-628.
47. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P., and Auwerx, J. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109-1122.
48. Landis, J. N., and Murphy, C. T. (2010). Integration of diverse inputs in the regulation of Caenorhabditis elegans DAF-16/FOXO. Dev. Dyn. 239, 1405-1412.
49. Lee, S. S., Kennedy, S., Tolonen, A. C., and Ruvkun, G. (2003). DAF-16 target genes that control C. elegans lifespan and metabolism. Science 300, 644-647.
50. Li, Y., Wang, W. J., Cao, H., Lu, J., Wu, C., Hu, F. Y., Guo, J., Zhao, L., Yang, F., Zhang, Y. X., Li, W., Zheng, G. Y., Cui, H., Chen, X., Zhu, Z., He, H., Dong, B., Mo, X., Zeng, Y., and Tian, X. L. (2009). Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Hum. Mol. Genet. 18, 4897-4904.
51. Li, Y., Xu, W., Mcburney, M. W., and Longo, V. D. (2008). SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab. 8, 38-48.
52. Link, C. D., Taft, A., Kapulkin, V., Duke, K., Kim, S., Fei, Q., Wood, D. E., and Sahagan, B. G. (2003). Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol. Aging 24, 397-413.
53. Luthi-Carter, R., Taylor, D. M., Pallos, J., Lambert, E., Amore, A., Parker, A., Moffitt, H., Smith, D. L., Runne, H., Gokce, O., Kuhn, A., Xiang, Z., Maxwell, M. M., Reeves, S. A., Bates, G. P., Neri, C., Thompson, L. M., Marsh, J. L., and Kazantsev, A. G. (2010). SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 107, 7927-7932.
54. Ma, T. C., Buescher, J. L., Oatis, B., Funk, J. A., Nash, A. J., Carrier, R. L., and Hoyt, K. R. (2007). Metformin therapy in a transgenic mouse model of Huntington's disease. Neurosci. Lett. 411, 98-103.
55. Mai, A., Valente, S., Meade, S., Carafa, V., Tardugno, M., Nebbioso, A., Galmozzi, A., Mitro, N., De Fabiani, E., Altucci, L., and Kazantsev, A. (2009). Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. J. Med. Chem. 52, 5496-5504.
56. Maxwell, M. M., Tomkinson, E. M., Nobles, J., Wizeman, J. W., Amore, A. M., Quinti, L., Chopra, V., Hersch, S. M., and Kazantsev, A. G. (2011). The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum. Mol. Genet. 20, 3986-3996.
57. McElwee, J., Bubb, K., and Thomas, J. H. (2003). Transcriptional outputs of the Caenorhabditis elegans forkhead protein DAF-16. Aging Cell 2, 111-121.
58. Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., and Westphal, C. H. (2007). Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716.
59. Morley, J. F., Brignull, H. R., Weyers, J. J., and Morimoto, R. I. (2002). The threshold for polyglutamineexpansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 16, 16.
60. Murphy, C. T. (2006). The search for DAF-16/FOXO transcriptional targets: approaches and discoveries. Exp. Gerontol. 41, 910-921.
61. Murphy, C. T., Mccarroll, S. A., Bargmann, C. I., Fraser, A., Kamath, R. S., Ahringer, J., Li, H.,and Kenyon, C. (2003). Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277-283.
62. Narasimhan, S. D., Yen, K., and Tissenbaum, H. A. (2009). Converging pathways in lifespan regulation. Curr. Biol. 19, R657-R666.
63. Oh, S. W., Mukhopadhyay, A., Dixit, B. L., Raha, T., Green, M. R., and Tissenbaum, H. A. (2006). Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation. Nat. Genet. 38, 251-257.
64. Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J. C., Mclean, P. J., Young, A. B., Abagyan, R., Feany, M. B., Hyman, B. T., and Kazantsev, A. G. (2007). Sirtuin 2 inhibitors rescue alphasynuclein-mediated toxicity in models of Parkinson's disease. Science 317, 516-519.
65. Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., Qiu, X., Stockman, B., Thanabal, V., Varghese, A., Ward, J., Withka, J., and Ahn, K. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285, 8340-8351.
66. Paik, J. H., Ding, Z., Narurkar, R., Ramkissoon, S., Muller, F., Kamoun, W. S., Chae, S. S., Zheng, H., Ying, H., Mahoney, J., Hiller, D., Jiang, S., Protopopov, A., Wong, W. H., Chin, L., Ligon, K. L., and Depinho, R. A. (2009). FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell 5, 540-553.
67. Pallos, J., Bodai, L., Lukacsovich, T., Purcell, J. M., Steffan, J. S., Thompson, L. M., and Marsh, J. L. (2008). Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum. Mol. Genet. 17, 3767-3775.
68. Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., and Neri, C. (2005). Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37, 349-350.
69. Parker, J. A., Connolly, J. B., Wellington, C., Hayden, M., Dausset, J., and Neri, C. (2001). Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc. Natl. Acad. Sci. U.S.A. 98, 13318-13323.
70. Pasco, M. Y., Rotili, D., Altucci, L., Farina, F., Rouleau, G. A., Mai, A., and Neri, C. (2010). Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues. J. Med. Chem. 53, 1407-1411.
71. Patel, K. R., Scott, E., Brown, V. A., Gescher, A. J., Steward, W. P., and Brown, K. (2011). Clinical trials of resveratrol. Ann. N. Y. Acad. Sci. 1215, 161-169.
72. Ramadori, G., Fujikawa, T., Anderson, J., Berglund, E. D., Frazao, R., Michan, S., Vianna, C. R., Sinclair, D. A., Elias, C. F., and Coppari, R. (2011). SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. Cell Metab. 14, 301-312.
73. Ramadori, G., Fujikawa, T., Fukuda, M., Anderson, J., Morgan, D. A., Mostoslavsky, R., Stuart, R. C., Perello, M., Vianna, C. R., Nillni, E. A., Rahmouni, K., and Coppari, R. (2010). SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab. 12, 78-87.
74. Rand, J. B., and Johnson, C. D. (1995). Genetic pharmacology: interactions between drugs and gene products in Caenorhabditis elegans. Methods Cell Biol. 48, 187-204.
75. Renault, V. M., Rafalski, V. A., Morgan, A. A., Salih, D. A., Brett, J. O., Webb, A. E., Villeda, S. A., Thekkat, P. U., Guillerey, C., Denko, N. C., Palmer, T. D., Butte, A. J., and Brunet, A. (2009). FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 5, 527-539.
76. Richard, T., Pawlus, A. D., Iglesias, M. L., Pedrot, E., Waffo-Teguo, P., Merillon, J. M., and Monti, J. P. (2011). Neuroprotective properties of resveratrol and derivatives. Ann. N. Y. Acad. Sci. 1215, 103-108.
77. Rizki, G., Iwata, T. N., Li, J., Riedel, C. G., Picard, C. L., Jan, M., Murphy, C. T., and Lee, S. S. (2011). The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF16/FOXO. PLoS Genet. 7, e1002235. doi:10.1371/journal.pgen.1002235
78. Schuff, M., Siegel, D., Bardine, N., Oswald, F., Donow, C., and Knochel, W. (2010). FoxO genes are dispensable during gastrulation but required for late embryogenesis in Xenopus laevis. Dev. Biol. 337, 259-273.
79. Schuster, E., Mcelwee, J. J., Tullet, J. M., Doonan, R., Matthijssens, F., Reece-Hoyes, J. S., Hope, I. A., Vanfleteren, J. R., Thornton, J. M., and Gems, D. (2010). DamID in C. elegans reveals longevity-associated targets of DAF-16/FoxO. Mol. Syst. Biol. 6, 399.
80. Siegrist, S. E., Haque, N. S., Chen, C. H., Hay, B. A., and Hariharan, I. K. (2010). Inactivation of both Foxo and reaper promotes long-term adult neurogenesis in Drosophila. Curr. Biol. 20, 643-648.
81. Smith, J. J., Kenney, R. D., Gagne, D. J., Frushour, B. P., Ladd, W., Galonek, H. L., Israelian, K., Song, J., Razvadauskaite, G., Lynch, A.V., Carney, D. P., Johnson, R. J., Lavu, S., Iffland, A., Elliott, P. J., Lambert, P. D., Elliston, K. O., Jirousek, M. R., Milne, J. C., and Boss, O. (2009). Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst. Biol. 3, 31. doi:10.1186/1752-0509-3-31
82. Soerensen, M., Dato, S., Christensen, K., Mcgue, M., Stevnsner, T., Bohr, V. A., and Christiansen, L. (2010). Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data. Aging Cell 9, 1010-1017.
83. Steinberg, G. R.,and Kemp, B. E. (2009). AMPK in health and disease. Physiol. Rev. 89, 1025-1078.
84. Taylor, D. M., Balabadra, U., Xiang, Z., Woodman, B., Meade, S., Amore, A., Maxwell, M. M., Reeves, S., Bates, G. P., Luthi-Carter, R., Lowden, P. A., and Kazantsev, A. G. (2011).A brainpermeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase. ACS Chem. Biol. 6, 540-546.
85. Tissenbaum, H. A., and Guarente, L. (2001). Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230.
86. Vingtdeux, V., Davies, P., Dickson, D. W., and Marambaud, P. (2011). AMPK is abnormally activated in tangleand pre-tangle-bearing neurons inAlzheimer's disease and other tauopathies. Acta Neuropathol. 121, 337-349.
87. Viswanathan, M., and Guarente, L. (2011). Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes. Nature 477. doi:10.1038/nature10440
88. Walker, F. O. (2007). Huntington's disease. Lancet 369, 218-228.
89. Wang, F., Chan, C. H., Chen, K., Guan, X., Lin, H. K., and Tong, Q. (2011). Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2mediated FOXO3 ubiquitination and degradation. Oncogene.doi: 10.1038/onc.2011.347. [Epub ahead of print].
90. Wang, F., Nguyen, M., Qin, F. X., and Tong, Q. (2007). SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6, 505-514.
91. Willcox, B. J., Donlon, T. A., He, Q., Chen, R., Grove, J. S., Yano, K., Masaki, K. H., Willcox, D. C., Rodriguez, B., and Curb, J. D. (2008). FOXO3A genotype is strongly associated with human longevity. Proc. Natl. Acad. Sci. U.S.A. 105, 13987-13992.
92. Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., and Sinclair, D. (2004). Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689.
93. Yen, K., Narasimhan, S. D., and Tissenbaum, H. A. (2011). DAF16/Forkhead box O transcription factor: many paths to a single Fork(head) in the road. Antioxid. Redox Signal. 14, 623-634.
94. Yu, R. X., Liu, J., True, N., and Wang, W. (2008). Identification of direct target genes using joint sequence and expression likelihood with application to DAF-16. PLoS ONE 3, e1821. doi:10.1371/journal.pone.0001821
95. Yuan, Z., Lehtinen, M. K., Merlo, P., Villen, J., Gygi, S., and Bonni, A. (2009). Regulation of neuronal cell death by MST1-FOXO1 signaling. J. Biol. Chem. 284, 11285-11292.
96. Zhao, Y., Yang, J., Liao, W., Liu, X., Zhang, H., Wang, S., Wang, D., Feng, J., Yu, L., and Zhu, W. G. (2010). Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol. 12, 665-675.
97. Zuccato, C., Valenza, M., and Cattaneo, E. (2010). Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol. Rev. 90, 905-981.